Tiagabine is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures.
Tiagabine HCl
Specifications
Human
Oral
Commercial
FEATURED Products
Related Media
New Product Development
Where our FDA approved laboratory begins developing products, formulating and validating methods to ensure quality.
Compliance Audits
Where we audit and champion our partner factories to exceed cGMP standards set by authorities.
Regulatory Services
Where all submissions are filed with the knowledge and experience of our 550+ worldwide approvals on record.